Skip to main content
OpenTrials
Completed

NCT Number: NCT02266459

Study to Evaluate Performance, Usability, Safety of Microwave Technology When Collecting Data From Patients With Stroke

This is a prospective, open, multicenter study that will enroll patients admitted to and hospitalized at the Stroke Unit due to diagnosed stroke and healthy volunteers.

The main purpose of the study is to evaluate the ability of the Microwave Technology to deliver adequate measurement data.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Strokeenheten, Södra Älvsborgs Sjukhus, Borås, Sweden

Loading trial locations.

About this study

After written informed consent has been acquired a physical examination will be performed followed by confirmation of the inclusion/exclusion criteria. After subject enrollment the microwave measurement will be performed. The procedure will take approximately 15 minutes (the duration of the actual measurements is < 1 minute) and will not interfere with the patient's standard of care at the Stroke Unit.

The measurement data will be evaluated for the presence of signal artifacts. The diagnostic ability of the device will be evaluated using a leave-one-out cross validation method with the CT diagnosis as ground truth. Microwave signals are sensitive to the dielectric parameters of the investigated object. In biological matter this is often related to amount of water. Brain tissue has different dielectric properties from blood. The physiological changes inside the brain that occurs as a result of a stroke will change the dielectric parameters.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

(Group A)

  • Signed Informed Consent Form
  • Patient diagnosed (by CT) with ischemic stroke, within 24 hours of stroke onset
  • Patient should be ≥ 18 years of age

(Group B)

  • Signed Informed Consent Form
  • Patient diagnosed (by CT) with hemorrhagic stroke, within 48 hours of stroke onset
  • Patient should be ≥ 18 years of age

(Group C)

  • Signed Informed Consent Form
  • Subject should be ≥ 18 years of age

Exclusion criteria

(Group A+B)

  • Pregnant or nursing woman
  • Woman of child bearing potential and not taking adequate contraceptive precautions
  • Patient that has already received thrombolytic treatment
  • Patient participating in any other clinical study that could interfere with the result in the present study
  • Patient diagnosed with a condition associated with risk of poor protocol compliance
  • Any other condition or symptoms preventing the patient from entering the study, according to the investigator´s judgment
  • Any patient that according to the Declaration of Helsinki is deemed unsuitable for study enrollment

(Group C)

  • Pregnant or nursing woman
  • Woman of child bearing potential and not taking adequate contraceptive precautions
  • Subject participating in any other clinical study that could interfere with the result in the present study
  • Any other condition or symptoms preventing the subject from entering the study, according to the investigator´s judgment
  • Any subject that according to the Declaration of Helsinki is deemed unsuitable for study enrolment

Treatment and study plan

Microwave technology (Medfield Diagnostics)

Device

A microwave measurement will be performed. The procedure will take approximately 15 minutes (the duration of the actual measurements is < 1 minute) and will not interfere with the patient's standard of care at the Stroke Unit.

Primary outcomes

  1. Ability to deliver adequate measurement data

    Time frame: The procedure will take approximately 15 minutes

    To confirm that the device will deliver adequate measurement data for at least 80 % of the patients diagnosed with Hemorrhagic stroke and Ischemic stroke

Secondary outcomes

  1. To confirm that the device will deliver adequate measurement data for at least 80 % of the healthy volunteers

    Time frame: The procedure will take approximately 15 minutes

  2. Mean time (± standard deviation) needed to complete the measurement procedure for group A + B + C

    Time frame: The procedure will take approximately 15 minutes

  3. To confirm the diagnostic ability of the device using a leave-one-out cross validation method

    Time frame: The procedure will take approximately 15 minutes

  4. Occurrence of adverse events

    Time frame: 24 hours

Sponsors and collaborators

Lead sponsor

Medfield Diagnostics

Industry

Registry information

Official study title

A Prospective, Open, Multicenter Study to Evaluate the Performance, Safety and Usability of the Microwave Technology Developed by Medfield Diagnostics When Collecting Measurement Data From Patients With Clinical Signs of Stroke.

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Oct 17, 2014
Registry last updated
Aug 11, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.